A pharmacology review covering GABA receptor-acting sedative-hypnotics including Selank. Positions Selank alongside benzodiazepines, GHB, and phenibut as a GABA-modulating compound used both therapeutically and illicitly. Notes Selank's anxiolytic properties and abuse potential, and discusses the regulatory challenges posed by novel peptide anxiolytics available outside formal medical channels.
Doyno, Cassandra R; White, C Michael